Synthesis of novel ketoconazole derivatives as inhibitors of the human Pregnane X Receptor (PXR; NR1I2; also termed SXR, PAR)

https://doi.org/10.1016/j.bmcl.2008.06.018Get rights and content

Abstract

PXR, pregnane X receptor, in its activated state, is a validated target for controlling certain drug–drug interactions in humans. In this context, there is a paucity of inhibitors directed toward activated PXR. Using prior observations with ketoconazole as a PXR inhibitor, the target compound 3 was synthesized from (s)-glycidol with overall 56% yield. (+)-Glycidol was reacted with 4-bromophenol and potassium carbonate in DMF to yield the ring opened compound 6. This was then heated to reflux in benzene along with 2′, 4′-difluoroacetophenone and catalytic amount of para-toluene sulfonic acid to yield 8. The resultant acetal 8 was then functionalized using Palladium chemistry to yield the target compound 3. The activity of the compound was compared with ketoconazole and UCL2158H. However, in contrast with ketoconazole (IC50  0.020 μM; ∼100% inhibition), 3 has negligible effects on inhibition of microsomal CYP450 (maximum ∼20% inhibition) at concentrations >40 μM. In vitro, micromolar concentration of ketoconazole is toxic to passaged human cell lines, while 3 does not exhibit cytotoxicity up to concentrations ∼100 μM (viability >85%). This is the first demonstration of a chemical analog of a PXR inhibitor that retains activity against activated PXR. Furthermore, in contrast with ketoconazole, 3 is less toxic in human cell lines and has negligible CYP450 activity.

Section snippets

Acknowledgment

The authors thank Dr. Matthew Redinbo, University of North Carolina, Chapel Hill, NC for insightful discussions regarding receptor structure.

References and notes (29)

  • D.J. Mangelsdorf et al.

    Cell

    (1995)
  • D.J. Mangelsdorf et al.

    Cell

    (1995)
  • A.K. Shiau et al.

    Cell

    (1998)
  • S.A. Kliewer et al.

    Mol. Cell.

    (1998)
  • E. Fayard et al.

    LRH-1: Trends Cell Biol.

    (2004)
  • A. Takeshita et al.

    J. Biol. Chem.

    (2002)
  • Y.C.E. Xue et al.

    Bioorg. Med. Chem.

    (2007)
  • E.C. Power et al.

    Biorg. Med. Chem. Lett.

    (2006)
  • P. Camps et al.

    Tetrahedron: Asymmetry

    (1995)
  • A. Chawla et al.

    Science

    (2001)
  • H. Gronemeyer et al.

    Nat. Rev. Drug Disc.

    (2004)
  • H.A. Ingraham et al.

    Curr. Opin. Struct. Biol.

    (2000)
  • D.P. McDonnell et al.

    Recent Prog. Horm. Res.

    (2002)
  • G. Bertilsson et al.

    Proc. Natl. Acad. Sci. U.S.A.

    (1998)
  • Cited by (0)

    View full text